Home/Filings/4/0000950170-24-069874
4//SEC Filing

Phillips Gary M. 4

Accession 0000950170-24-069874

CIK 0001341235other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:06 PM ET

Size

10.2 KB

Accession

0000950170-24-069874

Insider Transaction Report

Form 4
Period: 2024-06-04
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-04+3,4733,473 total
    Exercise: $4.09Exp: 2034-06-03Common Stock (3,473 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-04+40,28240,282 total
    Exercise: $4.09Exp: 2034-06-03Common Stock (40,282 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-04+2,6042,604 total
    Exercise: $4.09Exp: 2034-06-03Common Stock (2,604 underlying)
Footnotes (3)
  • [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
  • [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.
  • [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file

Issuer

Aldeyra Therapeutics, Inc.

CIK 0001341235

Entity typeother

Related Parties

1
  • filerCIK 0001197795

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:06 PM ET
Size
10.2 KB